ICH Q3B (R2) Impurities in new drug products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/ICH/2738/99
Published01/10/2006
Effective from01/08/2003
KeywordsFinished product, impurities, reporting, control, qualification, specifications
DescriptionThis document provides guidance on the content and qualification of impurities in new drug products for registration applications. It applies to drug products produced from chemically synthesised new drug substances not previously registered in a region or Member State.


Related content


How helpful is this page?

Average rating:

 Based on 1 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
1 ratings
    

Tell us more